Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.0B | 1.3B | 1.1B | 1.1B |
Cost of revenue | 404M | 449M | 385M | 378M |
Gross profit | 631M | 812M | 694M | 689M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 613M | 680M | 639M | 649M |
Other operating expenses | — | — | — | — |
Operating income | -30M | 83M | 6M | -7M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | -87M | -696M | -27M | -6M |
Pretax income | -102M | -605M | -11M | -9M |
Tax provision | 542M | -59M | -34M | 3M |
Net income | -644M | -546M | 23M | -12M |
Basic EPS | — | -4.6 | 0.2 | -0.1 |
Diluted EPS | — | -4.6 | 0.2 | -0.1 |
Basic average shares | — | 118.5M | 118.5M | 117.4M |
Diluted average shares | — | 118.5M | 118.8M | 117.4M |
EBITDA | 97M | 828M | 82M | 46M |
Net income from continuing op. | -644M | -546M | 23M | -12M |
Minority interests | -1M | -1M | 1M | -2M |
Preferred stock dividends | — | — | — | — |